Tuesday, 22 November 2016 07:45

Recall Of Respontin Nebules In Dublin

Rate this item
(2 votes)

The National Agency for Food and Drug Administration and Control has been informed that the Irish Health Product Regulatory Authority, Dublin announced the recall of four (4) batches of Respontin Nebules 250 microgram/1ml Respontin Nebules five hundred (500) microgram/2ml (Ipratropium Bromide) by GlaxoSmithKline over out of specification results for impurities .

Respontin Nebules is indicated for the treatment of reversible airway obstruction. It is used in a nebulizer, a machine that converts the liquid medicine inside the nebules into particles that can be inhaled.

The details of the recalled product are as follows:

i.   Batch Number: B76315Ba

Expiry date: 28/02/2017

Pack Size: 20x1ml

First distributed: 30th March, 2015

ii.   Batch Number: B85515J

Expiry date: 31/10/2017

Pack Size: 20x1ml

First distributed: 27th January, 2015

iii.  Batch Number: B76315BA

Expiry date: 28/02/2017

Pack Size: 4x5x2ml

First distributed: 29th May, 2015

iv.  Batch Number: B85515J

Expiry date: 31/10/2017

Pack Size: 4x5x2ml

First distributed: 18th December, 2015

Healthcare providers with stock of the products should immediately discontinue the administration or use of the products.

Healthcare professionals and consumers should report adverse events to NAFDAC PRASCOR (20543-Toll free from all networks) or via This email address is being protected from spambots. You need JavaScript enabled to view it.

 

NAFDAC…..Safeguarding the health of the Nation!!!

Read 3622 times Last modified on Tuesday, 22 November 2016 08:01

CORPORATE LINKS